Rare diseases
Investigational molecules
Locations
Researchdreef 60, 1070 Anderlecht, Belgium
Research activity includes Parkinson’s disease, Alzheimer’s disease, and progressive supranuclear palsy, with additional interest in brain pathophysiology and long-term neurological treatment outcomes.
The portfolio also extends to neurological symptom control in seizure disorders, including therapies for epilepsy, childhood absence epilepsy, juvenile absence epilepsy, and rapid treatment of prolonged seizure episodes.
UCB Biopharma runs clinical trials in conditions such as Myasthenia gravis, Psoriatic arthropathy, Psoriasis, Hidradenitis, among others.
Clinical trials run by this sponsor – those enrolling participants first.
A Study Testing How Well Bimekizumab Works and How Safe It Is for Adults with Palmoplantar Pustulosis
CzechiaStudy to measure bimekizumab concentration in breast milk of breastfeeding mothers with psoriasis, psoriatic arthritis, axial spondyloarthritis, or hidradenitis suppurativa
GermanyStudy on the Safety and Effectiveness of Alprazolam for Treating Long Seizures in Patients Aged 12 and Older
BulgariaStudy on the Safety of Alprazolam for Treating Long Seizures in Patients Aged 12 and Older
BulgariaStudy on Zilucoplan Sodium for Children Aged 2 to 17 with Generalized Myasthenia Gravis
ItalyStudy on the Effectiveness and Safety of Dapirolizumab Pegol for Patients with Moderate to Severe Systemic Lupus Erythematosus
BelgiumStudy on the Long-Term Safety of Dapirolizumab Pegol for Patients with Systemic Lupus Erythematosus
BelgiumStudy on the Long-Term Safety of Zilucoplan in Children with Generalized Myasthenia Gravis
ItalyStudy on the Safety and Body Processing of Bimekizumab in Children with Juvenile Idiopathic Arthritis
FrancePhase 3 Open‑Label Extension Study of Long‑Term Safety and Efficacy of Rozanolixizumab in Adults with Ocular Myasthenia Gravis
FranceA Phase 3 Randomized Study of Rozanolixizumab for Safety and Efficacy in Adults with Ocular Myasthenia Gravis
FranceStudy of dapirolizumab pegol placental transfer to infants in pregnant women with active systemic lupus erythematosus (drug combination)
AustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
